Loading clinical trials...
Loading clinical trials...
A Phase I, Randomized, Blinded and Placebo-controlled Trial to Evaluate the Safety, Tolerability, and Potential Efficacy of Allogeneic Human Mesenchymal Stem Cell Infusion in Patients With Idiopathic Pulmonary Fibrosis
Conditions
Interventions
Allogeneic Adult Human Mesenchymal Stem Cells (hMSCs)
matched placebo
Locations
1
United States
Interdisciplinary Stem Cell Institute / University of Miami
Miami, Florida, United States
Start Date
November 13, 2013
Primary Completion Date
December 11, 2015
Completion Date
November 24, 2016
Last Updated
March 9, 2021
NCT07466420
NCT07332117
NCT05975983
NCT04598919
NCT07179562
NCT06922916
Lead Sponsor
Joshua M Hare
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions